• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

Institut Mérieux S.A.

With extensive experience in industrial biology, Institut Mérieux contributes to serving medicine and public health across the globe. For the fight against infectious diseases and cancer, it imagines and develops new approaches in the fields of diagnostics, immunotherapy, and food safety and nutrition. With its three business activities- bioMérieux, Transgene and Silliker-Institut Mérieux has the potential to provide answers to the new challenges of public health globally: personalized medicine and new therapies, infectious diseases and cancer, food safety and nutrition. bioMérieux, listed on NYSE Euronext Paris and 59% owned, is based in Marcy l'Etoile (France). World leader of in vitro diagnostics and industrial microbiological controls. Transgene: Based in Strasburg (France), this biotech company is 55% controlled and is listed on NYSE Euronext Paris. It develops immunotherapy products for the treatment of cancer and infectious diseases. www.transgene.fr Silliker is a privately-owned company, 86% controlled, based in Chicago (United States), encompassing a network of nearly 50 laboratories dedicated to improving food safety and nutrition. www.silliker.com Institut Mérieux employs nearly 10,000 people in the service of public health worldwide and generates net sales of over 1.4 billion Euros. *

 

	Start	1990-01-01 existent
	Group	Mérieux (Group)
	Industry	in vitro diagnostics (IVD)
	Industry 2	food analysis (food testing)
	Region	Lyon
	Country	France
	City	n. a. Lyon
		Address record changed: 2011-05-15
Basic data	Employees	G: 5,001 to 10,000 (2010-08-12)
	Currency	EUR
	Annual sales	1,400,000,000 (net sales (2009) 2009-12-31)
		* Document for »About Section«: A*STAR. (8/12/10). "Press Release: A*STAR and Institut Mérieux/bioMérieux Invest S$3m in Tuberculosis Research. Partnership Could Lead to Improved Detection and Treatment of the Highly Infectious Disease that Affects Millions Worldwide".
		Record changed: 2011-11-27

More documents for Mérieux (Group)

• [1] bioMérieux S.A.. (6/22/11). "Press Release: bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety". Marcy l’Etoile....
• [2] bioMérieux S.A.. (5/19/11). "Press Release: bioMérieux Becomes the World Leader in Food Testing with AES Laboratoire Acquisition". Marcy l’Etoile....
• [3] bioMérieux S.A.. (5/5/11). "Press Release: bioMérieux and Labor Berlin (Charité Vivantes GmbH) to Establish Center of Excellence in Laboratory Diagnostics". Berlin & Marcy l’Etoile....
• [4] bioMérieux S.A.. (3/8/11). "Press Release: bioMérieux – 2010 Financial Results". Marcy l’Étoile....
• [5] bioMérieux S.A.. (1/19/11). "Press Release: bioMérieux – 2010 Business Review". Marcy l’Étoile....
• [6] bioMérieux S.A.. (9/6/10). "Press Release: First-half 2010 Results". Marcy-l’Étoile....
• [7] bioMérieux S.A.. (7/22/10). "Press Release: First-half 2010 Business Review". Marcy-l’Étoile....
• [8] bioMérieux S.A.. (5/21/10). "Press Release: Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Microbiology". Kyoto & Marcy l’Etoile....
• [9] bioMérieux S.A.. (5/17/10). "Press Release: bioMérieux Strengthens North American Executive Management Team. Manuel Mendez to serve as Executive Vice President, Commercial Operations for bioMérieux Inc.". Marcy l’Étoile....
• [10] bioMérieux S.A.. (4/21/10). "Press Release: bioMérieux and Knome Sign Startegic Partnership". Marcy l’Étoile & Cambridge, MA....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.